Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis

International Journal of Cardiovascular Imaging

Volumn 28, Issue 8, 2012, Pages 1879-1886

  Hou, Jingbo ^a   Jia, Haibo ^a   Liu, Haixia ^a   Han, Zhigang ^a   Yang, Shuang ^a   Xu, Chenyang ^b   Schmitt, Joseph ^b   Zhang, Shaosong ^a   Yu, Bo ^a   Jang, Ik Kyung ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b LightLab Imaging Inc   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Neointima coverage; Neointima heterogeneity; Optical coherence tomography; Sirolimus eluting stent

Indexed keywords

RAPAMYCIN;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT DURATION;

AGED; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LOGISTIC MODELS; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOINTIMA; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SIROLIMUS; SOFTWARE; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84870505393     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-012-0031-7     Document Type: Article

References (29)

1. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A (2007) Long-termsafety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 115(25):3181-3188.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773-1780.
3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349(14):1315-1323.
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126-2130.
5. Takano M, Mizuno K (2006) Late coronary thrombosis in a sirolimus-eluting stent due to the lack of neointimal coverage. Eur Heart J 27(10):1133.
6. Habara M, Terashima M, Suzuki T (2009) Detection of atherosclerotic progression with rupture of degenerated in-stent intima five years after bare-metal stent implantation using optical coherence tomography. J Invasive Cardiol 21(10):552-553.
7. Chamie D, Abizaid A, Costa JR Jr, Feres F, Almiro da Silva JF, Mattos LA, Staico R, Costa RA, Tanajura LF, Sousa AG, Sousa JE (2011) Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after cypher(R) sirolimus-eluting stent implantation. Int J Cardiovasc Imaging 27(6):867-874.
8. Welt FG, Rogers C (2002) Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22(11):1769-1776.
9. Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C (2003) Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med 8(1):1-7.
10. Zimmermann A, Pollinger B, Rieber J, Konig A, Erhard I, Krotz F, Sohn HY, Kantlehner R, Haimerl W, Duhmke E, Leibig M, Theisen K, Klauss V, Schiele TM (2005) Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis. Z Kardiol 94(4):239-246.
11. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, van der Giessen W, Regar E (2009) Optical coherence tomography patterns of stent restenosis. Am Heart J 158(2):284-293.
12. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E (2009) Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv 2(5):445-452.
13. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, Kaitani K, Inoue K, Nakagawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H, Nobuyoshi M(2002) Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105(25):2986-2991.
14. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz HT, Tearney GJ (2002) Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 39(4):604-609.
15. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ (2002) Characterization of human atherosclerosis by optical coherence tomography. Circulation 106(13):1640-1645.
16. Kim JS, Fan C, Choi D, Jang IK, Lee JM, Kim TH, Park SM, Paik SI, Ko YG, Hong MK, Jang Y, Chung N (2011) Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol 146(3):341-346.
17. Moore P, Barlis P, Spiro J, Ghimire G, Roughton M, Di Mario C, Wallis W, Ilsley C, Mitchell A, Mason M, Kharbanda R, Vincent P, Sherwin S, Dalby M (2009) A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycineluting stents. JACC Cardiovasc Interv 2(5):437-444.
18. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, Mizuno K (2009) Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 55(1):26-32.
19. Kitabata H, Tanaka A, Kubo T, Takarada S, Kashiwagi M, Tsujioka H, Ikejima H, Kuroi A, Kataiwa H, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Hirata K, Nakamura N, Mizukoshi M, Imanishi T, Akasaka T (2010) Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease. Am J Cardiol 105(12):1673-1678.
20. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T (2010) Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the registry of stent thrombosis for review and reevaluation (RESTART). Circulation 122(1):52-61.
21. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med 350(3):221-231.
22. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45(12):2088-2092.
23. Sawada T, Shite J, Shinke T, Tanino Y, Ogasawara D, Kawamori H, Kato H, Miyoshi N, Yoshino N, Hirata K (2008) Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography. J Cardiol 52(3):290-295.
24. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM (2000) Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 35(1):157-163.
25. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T, Seino Y, Mizuno K (2008) Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 51(9):968-969.
26. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, Sawada T, Paredes OL, Hirata K, Yokoyama M(2007) Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28(8):961-967.
27. Takano M, Mizuno K (2007) Angioscopic findings after drug-eluting stent implantation. Herz 32(4):281-286.
28. Asakura M, Ueda Y, Nanto S, Hirayama A, Adachi T, Kitakaze M, Hori M, Kodama K (1998) Remodeling of instent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up. Circulation 97(20):2003-2006.
29. Isner JM, Kearney M, Bortman S, Passeri J (1995) Apoptosis in human atherosclerosis and restenosis. Circulation 91(11):2703-2711.